Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19

被引:4
|
作者
Shakrawal, Jyoti [1 ]
Sharma, Vidhu [2 ]
Goyal, Amit [2 ]
Kumar, Deepak [3 ]
Meena, Seema [1 ]
Tiwari, Sarbesh [4 ]
Jain, Vidhi [5 ]
Elhence, Poonam [6 ]
Soni, Kapil [2 ]
Choudhury, Bikram [2 ]
Bhatnagar, Kavita [1 ]
Garg, Mahendra Kumar [3 ]
Misra, Sanjeev [7 ]
机构
[1] All India Inst Med Sci AIIMS, Dept Ophthalmol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[2] All India Inst Med Sci AIIMS, Dept Otorhinolaryngol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[3] All India Inst Med Sci AIIMS, Dept Gen Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[4] All India Inst Med Sci AIIMS, Dept Diagnost & Intervent Radiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[5] All India Inst Med Sci AIIMS, Dept Microbiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[6] All India Inst Med Sci AIIMS, Dept Pathol & Lab Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[7] All India Inst Med Sci AIIMS, Dept Surg Oncol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
关键词
COVID-19; Transcutaneous retrobulbar Amphotericin B; Rhino-orbital-cerebral-mucormycosis; MANAGEMENT;
D O I
10.1007/s10792-022-02591-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To assess the outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) for rhino-orbital-cerebral-mucormycosis (ROCM) post-COVID-19, as an adjuvant to standard systemic antifungal therapy. Methods In this prospective cohort study involving ROCM patients with clinical/radiological orbital involvement, 44 eyes with ROCM stage >= 3B received TRAMB for 7 consecutive days with liposomal Amphotericin-B (3.5 mg/ml) with a minimum clinical and radiological follow-up of 3 months. All patients received standard systemic antifungal therapy also as per institutional protocol. Data pertaining to demography, systemic status, clinical involvement, imaging, surgical/medical management were also recorded. Potential eyes for exenteration were excluded. Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Author 12 Given name: [Mahendra Kumar ] Last name [Garg]. Also, kindly confirm the details in the metadata are correct.All author names are presented accurately. Details in the metadata are correct. Thank you. Results Forty-four eyes of 42 patients were included, out of which 30 had diabetes mellitus & 22 had received steroid/oxygen treatment during COVID-19 infection. Forty eyes showed improvement or stable disease on follow-up on radiology. Four eyes which showed progression of the disease in orbit were reaugmented with TRAMB. No patient required exenteration. Subconjunctival haemorrhage occurred in six eyes and temporary blurring of vision in four eyes after TRAMB which resolved spontaneously. Conclusion TRAMB, as an adjuvant to standard systemic antifungal therapy, is associated with a significant reduction or stabilisation of orbital involvement. TRAMB should be considered as an adjuvant therapy for ROCM to reduce disease progression as well as to preserve globe or sight. It has a promising role in preventing potential orbital exenterations.
引用
收藏
页码:1919 / 1926
页数:8
相关论文
共 50 条
  • [1] Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19
    Jyoti Shakrawal
    Vidhu Sharma
    Amit Goyal
    Deepak Kumar
    Seema Meena
    Sarbesh Tiwari
    Vidhi Jain
    Poonam Elhence
    Kapil Soni
    Bikram Choudhury
    Kavita Bhatnagar
    Mahendra Kumar Garg
    Sanjeev Misra
    International Ophthalmology, 2023, 43 : 1919 - 1926
  • [2] Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review
    Nair, Akshay Gopinathan
    Dave, Tarjani Vivek
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2022, 41 (03): : 275 - 286
  • [3] Outcomes of Transcutaneous Retrobulbar Amphotericin B in Rhino-Orbital-Cerebral Mucormycosis Among Patients Recovering From COVID-19: A Preliminary Experience
    Sinha, Shivani
    Kumar, Vidya B.
    Kumar, Abhay
    Singh, Vivek
    Anand, Abhishek
    Kusumesh, Rakhi
    Mishra, Sarita
    Raj, Pragati
    Sinha, Bibhuti P.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [4] Transcutaneous retrobulbar amphotericin B for rhino-orbital-cerebral mucormycosis: a multi-center retrospective comparative study
    Dallalzadeh, Liane O. O.
    Ediriwickrema, Lilangi S. S.
    Fung, Sammie E. E.
    Men, Clara J. J.
    Kossler, Andrea L. L.
    Kupcha, Anna C. C.
    Mawn, Louise A. A.
    Burkat, Cat N. N.
    van Landingham, Suzanne W. W.
    Conger, Jordan R. R.
    Simmons, Brittany
    Pham, Chau
    Akella, Sruti S. S.
    Setabutr, Pete
    Ho, Tiffany
    Couch, Steven M. M.
    Kim, Jane S. S.
    Demirci, Hakan
    Korn, Bobby S. S.
    Kikkawa, Don O. O.
    Liu, Catherine Y. Y.
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2024, 43 (01): : 41 - 48
  • [5] Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study
    Gandhi, Aastha
    Narula, Anurag
    Chandra, Shreya
    Agarwal, Dhwanee
    Mehta, Anuj
    Nayak, Shaktiprada
    Arora, Sheetal
    Capoor, Malini R.
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (05) : 1571 - 1580
  • [6] Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study
    Aastha Gandhi
    Anurag Narula
    Shreya Chandra
    Dhwanee Agarwal
    Anuj Mehta
    Shaktiprada Nayak
    Sheetal Arora
    Malini R. Capoor
    International Ophthalmology, 2023, 43 : 1571 - 1580
  • [7] Alternating pattern of rhino-orbital-cerebral mucormycosis with COVID-19 in diabetic patients
    Eker, Caglar
    Tarkan, Ozgur
    Surmelioglu, Ozgur
    Dagkiran, Muhammed
    Tanrisever, Ilda
    Yucel Karakaya, Sevinc Puren
    Ulas, Burak
    Onan, Elvan
    Uguz, Aysun Hatice
    Ozdemir, Suleyman
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (01) : 219 - 226
  • [8] COVID-19 associated rhino-orbital-cerebral mucormycosis-an institutional series
    Naurka, Suresh
    Rana, Nishant
    Singh, Neeraj
    Kishore, Ameet
    Nagpal, Kalpana
    ENT-EAR NOSE & THROAT JOURNAL, 2024, 103 (1_SUPPL) : 134S - 144S
  • [9] First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria
    Niyazi, Denis
    Toncheva, Borislava
    Tonchev, Tsvetan
    Dzhenkov, Deyan
    Kalchev, Kalin
    Stoeva, Temenuga
    FUTURE MICROBIOLOGY, 2022, : 1107 - 1113
  • [10] Neuroimaging Findings in COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: A Review
    Reghunath, Anjuna
    Ghasi, Rohini Gupta
    Sharma, Anuradha
    Bagri, Neha
    Jain, Swarna Gupta
    INDIAN JOURNAL OF RADIOLOGY AND IMAGING, 2022, 32 (02) : 224 - 234